Showing results (201-210 of 256) with videos related to
Sort By:
Pageof 26
Journal of Autoimmunity|August 11, 1999
Inhibition of diabetes in NOD mice by idiotypic induction of SLEI Krause, Y Tomer, D Elias, et al.Journal of Autoimmunity|October 21, 2000
Production of neurotrophins by activated T cells: implications for neuroprotective autoimmunityG Moalem, A Gdalyahu, Y Shani, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1997
Stress and autoimmunity: the neuropeptides corticotropin-releasing factor and urocortin suppress encephalomyelitis via effects on both the hypothalamic-pituitary-adrenal axis and the immune systemS Poliak, F Mor, P Conlon, et al.The Journal of Surgical Research|June 29, 1999
Prolongation of rat skin and cardiac allograft survival by low molecular weight heparinO M Shapira, H Rene, O Lider, et al.The Journal of Pharmacology and Experimental Therapeutics|August 1, 1987
T lymphocyte line-mediated experimental allergic encephalomyelitis--a pharmacologic model for testing of immunosuppressive agents for the treatment of autoimmune central nervous system diseaseM E Westarp, H Wekerle, A Ben-Nun, et al.Neurology|January 21, 2012
Antigen microarrays identify CNS-produced autoantibodies in RRMSF J Quintana, M F Farez, G Izquierdo, et al.Cancer Research|November 15, 1994
Abnormal expression of perlecan proteoglycan in metastatic melanomasI R Cohen, A D Murdoch, M F Naso, et al.Blood|August 1, 1987
Inhibition of heparanase-mediated degradation of extracellular matrix heparan sulfate by non-anticoagulant heparin speciesM Bar-Ner, A Eldor, L Wasserman, et al.The Journal of Clinical Investigation|March 1, 1989
Suppression of experimental autoimmune diseases and prolongation of allograft survival by treatment of animals with low doses of heparinsO Lider, E Baharav, Y A Mekori, et al.Hepatology (Baltimore, Md.)|January 1, 1990
Experimental autoimmune hepatitis: disease induction, time course and T-cell reactivityA W Lohse, M Manns, H P Dienes, et al.Pageof 26